Licensed buy-back and resale of short-dated medicines between city chemists
TL;DR Shortdate is a city-level wholesaler that buys medicines with three to nine months of shelf life left from chemists who won't sell them in time, and resells them to nearby chemists who will. Chemists pay through the margin. It only works because a licensed wholesaler sits in the middle.
Every chemist carries a few slow lines. A strip that sells once a month in one locality may sell daily two kilometres away, near a different hospital or doctor. When the expiry date creeps close, the owner has three options - hope a rep takes it back, mark it down or bin it.
India has no public figure for how much chemist stock expires unsold, and we found no study on it. The scale of the trade is clear though. Pharmarack alone says its ordering network reaches over 2.3 lakh chemists and 15,900 distributors[1].
Evidence from abroad shows how informal the fix is. In a Jordanian survey, 38.5% of community pharmacists relied on reps collecting near-expiry items[2].
What it does, in regulatory terms: wholesale sale of drugs under a Form 20B/21B licence, not a peer-to-peer marketplace. The seed wanted shops sharing surplus with each other, and for medicines that runs straight into the licence system. A retail licence covers sale to patients, and selling by wholesale needs a licence issued in Form 20B or 21B under Rule 61 of the Drugs Rules[3]. So Shortdate holds that licence itself and is the legal buyer and seller of every strip.
Chemists list short-dated stock from their billing export or by photographing the strip. Shortdate prices each lot by days to expiry and local demand, collects it on a fixed weekly route, checks batch and condition, and offers it to chemists whose sales history suggests they'll clear it. Buyers get a discount on normal trade price and sellers get cash back on stock they would have written off.
Cold-chain products, Schedule X drugs and anything under six weeks to expiry stay out at launch. The software is simple. The business is the route, the licensed store and the trust of a few hundred chemists.
The chemist is both user and payer. The seller gets a buy-back price below what they paid, the buyer gets stock below normal trade price and Shortdate keeps the spread.
We found no public figure for typical expiry-return terms between distributors and chemists, so you'll have to test the spread in interviews. A second revenue line is a monthly fee for slow-stock reports built from the chemist's own billing data.
Chemists already order on apps. Pharmarack's network of over 2.3 lakh chemists[1] shows digital B2B ordering is normal in the trade, so listing a lot from a phone isn't a big ask. The DPDP Act, passed in August 2023, mostly concerns patient data, which this model never touches[4].
There is no public figure for the value of near-expiry medicine stock in India. The bottom-up case is the count - more than 2.3 lakh chemists on one ordering network alone[1].
Adjacent evidence - in Ethiopian public facilities, expiry made up 99.3% of medicine wastage over three years[5]. That's a very different setting, so treat it only as a sign that expiry drives waste.
Pharmarack runs B2B ordering and analytics for chemists and distributors, and its site lists no expiry exchange[1]. Distributors and company reps take some stock back, on terms that vary by company. We found no Indian service that moves short-dated stock from one chemist to another. Search tools were down during research, so check this before you start.
The gap is a licensed, local middleman whose only job is slow stock.
| Difficulty | Moderate (45/100) |
| Starting capital | ₹63 L–1.3 Cr |
| Time to launch | 6–9 months |
The licence is the gate. You need a compliant store, a competent person and clean batch records from day one. After that it's a route business, and margins are thin, so collection and delivery have to ride on runs you already make and pricing has to clear stock before it turns into your write-off.
Yes, this needs a drug licence before you buy or sell a single strip.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI judge whether a medicine is fit to sell or give any clinical advice. A competent person checks batch and condition, and the product does no diagnosis or treatment.
Want to work out the AI layer for Shortdate? Talk to Yash →
Here's what can go south -
I like this for someone from pharma distribution who already knows chemists by name and can run a licensed store. A software founder hoping to stay asset-light should pass. Before raising money, prove you can resell 70% of collected lots within 30 days in one city zone.
Plan for roughly ₹63 L–1.3 Cr, covering a licensed store, a competent person, a collection van and working capital for stock.
Yes. Buying and reselling medicines between chemists is wholesale, so you need a Form 20B or 21B licence from the state drugs controller and compliant premises.
Possibly, but medicine trade is licensed almost everywhere. Speak to your national drug regulator about wholesale rules before you collect anything.
The free Shortdate validation kit has the line-by-line capital breakdown, the effort scoring, the drug-licence checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for chemists, and 5 assumptions to test. Download the kit →
Thinking about building Shortdate or something close to it? The make-or-break work is pricing lots so they clear before expiry while the spread still covers the route, and that's exactly the kind of thing I help founders with. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.